Interferon treatment inhibits the replication of simian immunodeficiency virus at an early stage: Evidence for a block between attachment and reverse transcription

Virology

Volumn 241, Issue 1, 1998, Pages 156-162

  Taylor, Matthew D ^a   Korth, Marcus J ^a   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032005701     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8964     Document Type: Article

References (50)

1. Agy M. B., Wambach M., Foy K., Katze M. G. Expression of cellular genes in CD-4 positive lymphoid cells infected by the human immunodeficiency virus, HIV-1: Evidence for a host protein synthesis shutoff induced by cellular mRNA degradation. Virology. 177:1990;251-258.
2. Agy M. B., Foy K., Gale M. J., Benveniste R. E., Clark E. A., Katze M. G. Viral and cellular gene expression in CD4+ human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne. Virology. 183:1991;170-180.
3. Agy M. B., Acker R. L., Sherbert C. H., Katze M. G. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cells by distinct mechanisms: Evidence for decreased stability and aberrant processing of HIV-1 proteins. Virology. 214:1995;379-386.
4. Agy M. B., Sherbert C. H., Katze M. G. Development of anin vitro. Virology. 217:1996;158-166.
5. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
6. Baca-Regen L., Heinzinger N., Stevenson M., Gendelman H. E. Alpha interferon-induced antiretroviral activities: Restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J. Virol. 68:1995;7559-7565.
7. Barre-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 220:1983;868-871.
8. Brand S. R., Kobayashi R., Mathews M. B. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272:1997;8388-8395.
9. Chen Z., Zhou P., Ho D. D., Landau N. R., Marx P. A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:1997;2705-2714.
10. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
12. Clements J. E., Zink M. C. Molecular biology and pathogenesis of animal lentivirus infections. Clin. Microbiol. Rev. 9:1996;100-117.
13. Coccia E. M., Krust B., Hovanessian A. G. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J. Biol. Chem. 269:1994;23087-23094.
14. Daniel M. D., Letvin N. L., King N. W., Kannagi M., Sehgal P. K., Kanki P. J., Essex M., Desoriers R. C. Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques. Science. 228:1985;1201-1204.
15. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
16. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
17. Fernie B. F., Poli G., Fauci A. S. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells. J. Virol. 65:1991;3968-3971.
18. Foley G. E., Lazarus H., Farber S., Uzman B. G., Boone B. A., McCarthy R. E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 18:1965;522-529.
19. Francis M. L., Meltzer M. S., Gendelman H. E. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res. Hum. Retroviruses. 8:1992;199-207.
20. Gale M. Jr., Katze M. G. What happens inside a lentivirus or influenza virus infected cell: Insights into the regulation of cellular and viral protein synthesis. Methods: Companion Methods Enzymol. 11:1997;383-401.
21. Goncalves J., Korin Y., Zack J., Gabuzda D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:1996;8701-8709.
22. Hansen B. D., Nara P. L., Maheshwari R. K., Sidhu G. S., Bernbaum J. G., Hoekzema D., Meltzer M. S., Gendelman H. E. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J. Virol. 66:1995;7543-7548.
23. Harada S., Koyanagi Y., Yamamoto N. Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in plaque assay. Science. 229:1985;563-566.
24. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:1967;365-369.
25. Hovanessian A. G. Interferon-induced and dsRNA activated enzymes: A specific protein kinase and 2′-5′ oligodenylate synthetases. J. Interferon Res. 1:1991;199-205.
26. Hoxie J. A., Haggarty B. S., Bonser S. E., Rackowski J. L., Shan H., Kanki P. J. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. J. Virol. 62:1988;2557-2568.
27. Katze M. G. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3:1995;75-78.
28. Kestler H., Kodama T., Ringer D., Marthas M., Pedersen N., Lackner A., Reiger D., Sehgal P., Daniel M., King N., Desrosiers R. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 248:1990;1109-1112.
29. Khatissian E., Tovey M. G., Cumont M. C., Monceaux V., Lebon P., Montagnier L., Hurtrel B., Chakrabarti L. The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res. Hum. Retroviruses. 12:1996;1273-1278.
30. Kunzi M. S., Pitha P. M. Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication. J. Interferon Res. 16:1996;919-927.
31. mac. J. Acquired Immuno. Defic. Syndr. 5:1992;639-646.
32. Luciw P. A., Potter S. J., Steimer K., Dina D., Levy J. A. Molecular cloning of AIDS-associated retrovirus. Nature. 312:1984;760-763.
33. Marcon L., Choe H., Martin K. A., Farzan M., Ponath P. D., Wu L., Newman W., Gerard N., Gerard C., Sodroski J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71:1997;2522-2527.
34. McMillan N. A. J., Chun R. F., Siderovski D. P., Galabru J., Toone W. M., Samuel C. E., Mak T. W., Hovanessian A. G., Jeang K.-T., Williams B. R. G. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology. 213:1995;413-424.
35. Nagai K., Wong A. H., Li S., Tam N. W. N., Cuddihy A. R., Sonenberg N., Mathews M. B., Hiscott J., Wainberg M. A., Koromilas A. E. Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR. J. Virol. 71:1997;1718-1725.
36. Pitha P. Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antiviral Res. 24:1994;205-219.
37. Poli G., Biswas P., Fauci A. S. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res. 24:1994;221-233.
38. Roy S., Katze M. G., Parkin N. T., Edery I., Hovanessian A. G., Sonenberg N. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1tat. Science. 247:1990;1216-1219.
39. r. J. Virol. 65:1991;632-640.
40. Salahuddin S. Z., Markham P. D., Wong-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord lymphocytes. Virology. 129:1983;51-64.
41. Schellekens H., Niphuis H., Buijs L., Douw-van-der-Krap P., Hochkeppel H. K., Heeney J. L. The effect of recombinant human interferon alpha B/D compared to interferon alpha 2b on SIV infection in rhesus macaques. Antiviral Res. 32:1996;1-8.
42. Shirazi Y., Pitha P. M. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology. 193:1993;303-312.
43. Shirazi Y., Pitha P. M. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 66:1995;1321-1328.
44. Silverman R. H. Fascination with 2-5A-dependent RNase: A unique enzyme that functions in interferon action. J. Interferon Res. 14:1994;101-104.
45. Staehli P. Interferon induced proteins and the antiviral state. Adv. Virus Res. 38:1990;147-200.
46. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolf B., Peichl P., Palfi G., Schnitzel W., Mlynar E., Rosenwirth B. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication. J. Virol. 69:1995;814-824.
47. Thomas P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77:1980;5201-5205.
48. Uberla K., Stahl-Hennig C., Bottiger D., Matz-Rensing K., Kaup F., Li J., Haseltine W. A., Fleckenstein B., Hunsmann G., Oberg B., Sodroski J. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA. 92:1995;8210-8214.
49. Yu X., Matsuda Z., Yu Q., Lee T., Essex M. Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions. J. Virol. 67:1993;4386-4390.
50. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2′-5′A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell. 72:1993;753-765.